Sales up at bid target ProStrakan

first_img Share Sales up at bid target ProStrakan Show Comments ▼ ProStrakan, the pharmaceutical firm that has agreed to be bought by Japan’s Kyowa Hakko Kirin, narrowed its full-year loss after bouncing back from manufacturing problems. The Scottish firm reported a pre-tax loss of £600,000 against a loss of £15m a year ago, after a 27 per cent jump in revenues. ProStrakan reiterated that the £292m takeover bid fully valued the business. KCS-content Read This NextRicky Schroder Calls Foo Fighters’ Dave Grohl ‘Ignorant Punk’ forThe WrapCNN’s Brian Stelter Draws Criticism for Asking Jen Psaki: ‘What Does theThe WrapDid Donald Trump Wear His Pants Backwards? Kriss Kross Memes Have AlreadyThe WrapPink Floyd’s Roger Waters Denies Zuckerberg’s Request to Use Song in Ad:The WrapHarvey Weinstein to Be Extradited to California to Face Sexual AssaultThe Wrap2 HFPA Members Resign Citing a Culture of ‘Corruption and Verbal Abuse’The Wrap’The View’: Meghan McCain Calls VP Kamala Harris a ‘Moron’ for BorderThe Wrap’Black Widow’ First Reactions: ‘This Is Like the MCU’s Bond Movie’The Wrap’Small Axe’: Behind the Music Everyone Grooved On in Steve McQueen’sThe Wrap whatsapp whatsapp Thursday 17 March 2011 8:42 pm Tags: NULLlast_img